Keep Out Of Reach Of Children
Keep out of reach of children.
Bhi Uri-control
FDA Label NDC 62795-9004
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Bhi Uri-control (NDC 62795-9004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding keep out of reach of children, indications:, warnings:, directions:, active ingredients:, inactive ingredients:, purpose, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Indications:
For the temporary relief of minor
urinary pain and urgency.
Warnings:
If pregnant or breast-feeding, ask a
health professional before use. Keep out of reach
of children. If symptoms persist or worsen, a
healthcare provider should be consulted. Do not use
if known sensitivity to BHI Uri-Control or any of its
ingredients exists.
Directions:
Adults: 1-2 tablets 3 times per day or
as directed by a health practitioner. Not to exceed 6
tablets per 24 hours. Children under 18, as
directed by a health professional. Allow to
completely dissolve in the mouth
Active Ingredients:
Each 300 mg tablet contains:
*Apis mellifica 6X 30mg, Argentum nitricum 6X
30mg, *Belladonna 4X 30mg, *Cantharis 6X 30mg,
Causticum 8X 30mg, *Equisetum hyemale 6X 30mg,
*Petroselinum sativum 8X 30mg, *Pulsatilla 6X
30mg, *Sarsaparilla 6X 30mg, Terebinthina 8X 30mg.
*Natural
Inactive Ingredients:
*Dextrose, *Lactose,
Magnesium stearate, *Maltodextrin
*contains one or more of these ingredients
Purpose
Urinary Pain Relief
* Please review the disclaimer below.
